Terns Pharmaceuticals, Inc.
TERN
$25.79
-$1.74-6.32%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -94.44M | -91.75M | -90.39M | -88.85M | -88.07M |
| Total Depreciation and Amortization | 602.00K | 697.00K | 829.00K | 896.00K | 902.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.81M | 12.24M | 13.05M | 12.60M | 12.46M |
| Change in Net Operating Assets | 4.35M | 4.45M | 4.85M | 5.34M | -39.00K |
| Cash from Operations | -77.68M | -74.36M | -71.66M | -70.02M | -74.75M |
| Capital Expenditure | 0.00 | 0.00 | -13.00K | -42.00K | -86.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -42.39M | -35.14M | -18.44M | -12.37M | 129.26M |
| Cash from Investing | -42.39M | -35.14M | -18.45M | -12.41M | 129.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.02M | 164.38M | 164.46M | 164.38M | 177.63M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -319.00K | -394.00K | -394.00K | -388.00K | -75.00K |
| Cash from Financing | 696.00K | 163.99M | 164.06M | 164.00M | 177.55M |
| Foreign Exchange rate Adjustments | -68.00K | -20.00K | -33.00K | -56.00K | 268.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -119.44M | 54.47M | 73.92M | 81.51M | 232.24M |